+

WO1990010709A3 - Anticorps monoclonaux pour cations metalliques sur petites molecules - Google Patents

Anticorps monoclonaux pour cations metalliques sur petites molecules Download PDF

Info

Publication number
WO1990010709A3
WO1990010709A3 PCT/US1990/001401 US9001401W WO9010709A3 WO 1990010709 A3 WO1990010709 A3 WO 1990010709A3 US 9001401 W US9001401 W US 9001401W WO 9010709 A3 WO9010709 A3 WO 9010709A3
Authority
WO
WIPO (PCT)
Prior art keywords
monoclonal antibodies
fragments
small molecules
directed
metallic cations
Prior art date
Application number
PCT/US1990/001401
Other languages
English (en)
Other versions
WO1990010709A2 (fr
Inventor
Fred W Wagner
Dwane E Wylie
Sheldon M Schuster
Thomas R Coolidge
Pill-Soon Song
William Parker
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23263379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1990010709(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Nebraska filed Critical Univ Nebraska
Priority to DE69031909T priority Critical patent/DE69031909T2/de
Priority to CA002047717A priority patent/CA2047717C/fr
Priority to EP90905954A priority patent/EP0463110B1/fr
Priority to AU54114/90A priority patent/AU648022B2/en
Publication of WO1990010709A2 publication Critical patent/WO1990010709A2/fr
Publication of WO1990010709A3 publication Critical patent/WO1990010709A3/fr
Priority to FI914298A priority patent/FI100472B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Endoscopes (AREA)
  • Pressure Sensors (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des anticorps monoclonaux, leurs fragments, des chaînes individuelles et des imitateurs polypeptidiques de leurs régions hypervariables immuniréagissant avec des petites fractions simples telles que des cations métalliques et des petites molécules organiques, les hybridomes permettant la production des anticorps monoclonaux, des composés immunogènes permettant de développer les hybridomes, ainsi que des procédés d'utilisation des anticorps monoclonaux.
PCT/US1990/001401 1989-03-14 1990-03-14 Anticorps monoclonaux pour cations metalliques sur petites molecules WO1990010709A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE69031909T DE69031909T2 (de) 1989-03-14 1990-03-14 Monoklonale antikörper für metall kationen
CA002047717A CA2047717C (fr) 1989-03-14 1990-03-14 Anticorps monoclonaux contre de petites molecules et methodes pour les preparer
EP90905954A EP0463110B1 (fr) 1989-03-14 1990-03-14 Anticorps monoclonaux contre des cations metalliques
AU54114/90A AU648022B2 (en) 1989-03-14 1990-03-14 Monoclonal antibodies for metallic cations on small molecules
FI914298A FI100472B (fi) 1989-03-14 1991-09-12 Monoklonaalisia vasta-aineita metallikationeille

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32439289A 1989-03-14 1989-03-14
US324,392 1989-03-14

Publications (2)

Publication Number Publication Date
WO1990010709A2 WO1990010709A2 (fr) 1990-09-20
WO1990010709A3 true WO1990010709A3 (fr) 1990-11-15

Family

ID=23263379

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1990/001401 WO1990010709A2 (fr) 1989-03-14 1990-03-14 Anticorps monoclonaux pour cations metalliques sur petites molecules

Country Status (9)

Country Link
US (1) US5503987A (fr)
EP (2) EP0589487A1 (fr)
JP (1) JPH05504464A (fr)
AT (1) ATE161852T1 (fr)
AU (1) AU648022B2 (fr)
CA (1) CA2047717C (fr)
DE (1) DE69031909T2 (fr)
FI (1) FI100472B (fr)
WO (1) WO1990010709A2 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972656A (en) * 1989-03-14 1999-10-26 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefore
DE4007079A1 (de) * 1990-03-07 1991-09-12 Behringwerke Ag Monoklonale antikoerper gegen komplexierte und nicht komplexierte komplexbildner zur entfernung von schwermetallen aus waessrigen loesungen
AU8499691A (en) * 1990-09-05 1992-03-30 Neurex Corporation Method and composition for detecting bioactive peptides
US5273909A (en) * 1991-06-03 1993-12-28 Quantix Systems, L.P. Immunoassay for the detection of small aliphatic organic compounds
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US5459040A (en) * 1993-11-22 1995-10-17 The Regents Of The University Of California Enzyme amplified, complex linked, competitive and non-competitive assays for the detection of metal ions
US5476939A (en) * 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives
AU1695795A (en) * 1994-01-27 1995-08-15 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefor
WO1996039518A1 (fr) * 1995-06-05 1996-12-12 Bionebraska, Inc. Polypeptides fixant le plomb et nucleotides codants afferent
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
US5817527A (en) * 1995-11-06 1998-10-06 Chiron Diagnostics Corporation Conjugation of ligand to immobilized protein in organic solvent
US5962291A (en) * 1996-04-19 1999-10-05 The Regents Of The University Of Colorado Metal dependent catalytic antibodies and method for producing the same
DE69731983T2 (de) * 1996-08-19 2005-10-06 Shaker, Ghassan I. Verwendung von molt4 cd69 expression zur bestimmung der anwesenheit und der aktivität von interferoninhibitoren
US6190923B1 (en) 1997-09-05 2001-02-20 David K. Johnson Diethylenetriamine-N,N′,N″-triacetic acid derivatives
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7833528B2 (en) * 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7387772B1 (en) 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
US7074405B1 (en) * 1998-06-22 2006-07-11 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20030215952A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
CA2364983A1 (fr) * 2000-12-13 2002-06-13 John R. Coleman Molecules d'acide nucleique et polypeptides pour le catabolisme de l'acide abscisique
US20030049800A1 (en) * 2000-12-15 2003-03-13 Saravis Calvin A. Compositions and methods for producing antibodies to low molecular weight analytes
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US6686202B2 (en) * 2001-08-08 2004-02-03 Placer Dome, Inc. Methods for detecting and extracting gold
AU2002366640A1 (en) * 2001-12-11 2003-06-23 Expressive Constructs, Inc. Detection and removal of lead using lead-binding proteins
CN101921338A (zh) * 2004-03-31 2010-12-22 佳能株式会社 一种靶物质俘获体
US8021849B2 (en) * 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
US20090075342A1 (en) * 2005-04-26 2009-03-19 Sharon Cload Metabolic profile directed aptamer medicinal chemistry
US7189582B2 (en) * 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
US20100329983A1 (en) 2009-06-26 2010-12-30 Soricimed Biopharma Inc. Compounds and methods for the detection of trpv-6 cancers and drug delivery
CN113801220B (zh) * 2021-09-18 2023-07-07 青岛普瑞邦生物工程有限公司 一种米酵菌酸复合抗原、米酵菌酸抗体及其制备方法和酶联免疫试剂盒
CN114014934B (zh) * 2021-10-14 2023-05-05 江苏省农业科学院 多氯联苯单克隆抗体及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235457A2 (fr) * 1985-12-13 1987-09-09 Syngene International N.V. Anticorps monoclonaux
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5599072A (en) * 1979-01-24 1980-07-28 Mitsubishi Petrochem Co Ltd Production of artificial antigen containing choline residue
US4281065A (en) * 1979-01-25 1981-07-28 Syva Company Phencyclidine conjugates to antigenic proteins and enzymes
US4261974A (en) * 1979-11-13 1981-04-14 Miles Laboratories, Inc. Valproic acid immunogen conjugates and antibodies thereto
JPS5714748A (en) * 1980-07-01 1982-01-26 Dainippon Pharmaceut Co Ltd Kit for quantitative determination of valproic acid and its method for quantitative determination
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
JPS5838860A (ja) * 1981-08-31 1983-03-07 Dainippon Pharmaceut Co Ltd バルプロ酸の定量に用いるキツト及びその方法
US4681782A (en) * 1982-03-31 1987-07-21 Biostar Medical Products, Inc. Article for determining the presence of immune complexes
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
GB2131830A (en) * 1982-12-10 1984-06-27 Ludwig Inst Cancer Res Monoclonal antibody for use against breast cancer
US4456691A (en) * 1983-02-28 1984-06-26 Suad Stark Antigen for PCB, antibody raised by same, and method of making same
US4778752A (en) * 1983-10-11 1988-10-18 Scripps Clinic And Research Foundation Receptors specific for hapten-modified self proteins
FR2557458B1 (fr) * 1983-12-30 1987-09-04 Centre Nat Rech Scient Nouveaux anticorps capables de reconnaitre specifiquement des groupements hapteniques, leur preparation et leur application, et nouveaux antigenes permettant de les preparer
US4701408A (en) * 1984-01-30 1987-10-20 Smithkline Beckman Corporation Monoclonal antibody to activated macrophages
FR2561660B1 (fr) * 1984-03-26 1986-07-25 Centre Nat Rech Scient Nouveaux anticorps diriges contre un groupement haptenique contenant un motif choline, leur preparation et leur application, et nouveaux antigenes permettant de les preparer
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
EP0169645A1 (fr) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Composés de coordination du platine
EP0167310B1 (fr) * 1984-06-27 1991-05-29 Johnson Matthey Public Limited Company Composés de coordination du platine
CA1260827A (fr) * 1984-08-31 1989-09-26 Richard C. Siegel Complexes anticorps - ions metalliques
US4530786A (en) * 1984-09-04 1985-07-23 Colorado State University Research Foundation Antibody for the detection and quantification of atrazine
EP0198826A4 (fr) * 1984-10-29 1989-03-23 Eks Inc Procede d'analyse immunologique pour petites molecules.
JPS61145200A (ja) * 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
EP0194158A3 (fr) * 1985-03-08 1988-02-24 Baylor College of Medicine Anticorps antinicotine et anticotinine (monoclonaux et autres) et leurs applications dans des essais de nicotine et cotinine
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
DE3515901A1 (de) * 1985-05-03 1986-11-06 Battelle-Institut E.V., 6000 Frankfurt Verfahren zum nachweis von 1, 2, 2-trimethylpropylmethylphosphofluoridad
CA1302919C (fr) * 1985-07-03 1992-06-09 Robert T. Buckler Derives de l'histamine, conjugues immunogenes et antibiotiques obtenus a partir de ceux-ci
JPS6251699A (ja) * 1985-08-30 1987-03-06 Nichirei:Kk 単クロ−ン性抗体およびそれを用いる測定法
US4772551A (en) * 1985-12-26 1988-09-20 Neogen Corporation Method and test kit for detecting a trichothecene using novel monoclonal antibodies
US4797473A (en) * 1986-06-25 1989-01-10 Regents Of The University Of Minnesota Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
DE3632343A1 (de) * 1986-09-24 1988-04-07 Battelle Institut E V Verfahren zum nachweis von 1,2,2-trimethylpropylmethylphosphofluoridad
US4859613A (en) * 1986-11-12 1989-08-22 Lawrence David A Immunoassays for glutathione and antibodies useful therein
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
CA1339946C (fr) * 1987-03-31 1998-07-07 Michael J. Griffith Methode d'ultrapurification pour les polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates
EP0235457A2 (fr) * 1985-12-13 1987-09-09 Syngene International N.V. Anticorps monoclonaux

Also Published As

Publication number Publication date
CA2047717A1 (fr) 1990-09-15
WO1990010709A2 (fr) 1990-09-20
EP0589487A1 (fr) 1994-03-30
EP0463110A1 (fr) 1992-01-02
FI100472B (fi) 1997-12-15
DE69031909D1 (de) 1998-02-12
AU648022B2 (en) 1994-04-14
DE69031909T2 (de) 1998-04-16
US5503987A (en) 1996-04-02
AU5411490A (en) 1990-10-09
EP0463110B1 (fr) 1998-01-07
FI914298A0 (fi) 1991-09-12
CA2047717C (fr) 2000-08-01
ATE161852T1 (de) 1998-01-15
JPH05504464A (ja) 1993-07-15

Similar Documents

Publication Publication Date Title
WO1990010709A3 (fr) Anticorps monoclonaux pour cations metalliques sur petites molecules
DE69223641D1 (de) Stabilisierte antikörper
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
ES2091765T3 (es) Procedimiento de deteccion e identificacion de constituyentes que contienen acido nucleico.
DE59208982D1 (de) Verfahren zur Reinigung von IgG-monoklonalen Antikörpern
ATE346858T1 (de) Antikörperreinigung durch hydrophobe wechselwirkungchromatografie bei niedrigem ph
Saluk et al. The unique molecular weight of the heavy chain from human IgG3
CA2172663A1 (fr) Reactifs ameliores d'immuno-essai pour les cannabinoides
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
EP0251195A3 (en) Method and reagent for the determination of alpha-amylase
JPS6428560A (en) Immunometric measurement
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
FI91976C (fi) Menetelmä ja reagenssi follikkelia stimuloivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
FR2718849B1 (fr) Procédé d'immunodosage de l'antithrombine III activée par un glycosaminoglycane, anticorps monoclonaux correspondants et leur procédé d'obtention.
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
AU2562088A (en) Detection of tumor-associated markers in biological fluids
MY104917A (en) Monoclonal antibodies and methods for diagnosis of phytophora infection
KR910006712A (ko) 형광편광기술에 사용하기 위한 모노클로날 항체의 안정화
SE7904276L (sv) Renat cancerassocierat protein
ATE113935T1 (de) Radioaktive jodverbindung zur markierung von antikörpern.
KR860000561A (ko) 시알리레이티드 루이스^x항원의 검출법
FR2689246B1 (fr) Procede immunochimique de detection de l'origine d'une substance produite par genie genetique et reactifs pour sa mise en óoeuvre.
EP0184120A3 (fr) Traceurs pour l'essai de disopyramide et immunogènes pour la production d'anticorps
HUT61578A (en) Process for producing halogen methylketone pentapeptide derivatives usable as specific affinity reagent of opioid receptor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA DK FI HU JP KR NO SU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA DK FI HU JP KR NO SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PAT.BUL.22/90,UNDER INID (54) TITLE REPLACE THE EXISTING TEXT BY "MONOCLONAL ANTIBODIES FOR METALLIC CATIONS ON SMALL MOLECULES"

WWE Wipo information: entry into national phase

Ref document number: 2047717

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1990905954

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 914298

Country of ref document: FI

WWP Wipo information: published in national office

Ref document number: 1990905954

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 914298

Country of ref document: FI

WWG Wipo information: grant in national office

Ref document number: 1990905954

Country of ref document: EP

ENP Entry into the national phase

Ref country code: CA

Ref document number: 2047717

Kind code of ref document: A

Format of ref document f/p: F

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载